Código QR (código de barras bidimensional)

Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone

Abstract Objective Compare outcomes in patients with stage III non–small cell lung cancer (NSCLC) treated with chemoradiation and adjuvant durvalumab to historical controls treated with chemoradiation alone. Methods The records of patients with stage III NSCLC treated with definitive chemoradiation...

תיאור מלא

שמור ב:
Principais autores: Akram Saad, Jeffrey Goldstein, Sarit Appel, Sameh Daher, Damien Urban, Amir Onn, Hadas Gantz‐Sorotsky, Anastasiya Lobachov, Teodor Gottfried, Benjamin Spieler, Jair Bar
פורמט: Artigo
שפה:Inglês
יצא לאור: Wiley 2022-06-01
סדרה:Thoracic Cancer
נושאים:
durvalumab
immunotherapy
non–small cell lung cancer
PD‐L1
stage III
גישה מקוונת:https://doi.org/10.1111/1759-7714.14452
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים